Aurobindo and Unichem recall products in US market
The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation…
Aurobindo Pharma receives USFDA nod for Droxidopa Capsules
The product will be launched immediately
Lupin, Aurobindo recall drugs in US market
Lupin Pharma is recalling 46,479 bottles of Oseltamivir Phosphate for Oral Suspension while AuroMedics Pharma, a unit of Aurobindo…
Aurobindo, KAPL, Kinvan get approval under PLI scheme
The setting up of plants under the scheme will lead to a total committed investment of Rs 3,761 crore by the companies and…
Container shortage are delay pharma exports, affect sector’s financial performance: Industry
Stakeholders request government authorities to intervene and work out a solution on priority
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
Experts bat for global cooperation and coordination to tackle COVID-19 pandemic
Aurobindo Pharma to make COVAXX’s potential COVID-19 vaccine for India, UNICEF
Aurobindo Pharma said that it would make and sell US-based COVAXX’s COVID-19 vaccine candidate for supply in India and to the…
Aurobindo gets USFDA nod for dexmedetomidine HCL in 0.9% sodium chloride injection
The product will be launched in January 2021
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including…